G-CSF Primed Autologous Marrow Harvest and Transplantation in Cytapheresis “Mobilization Failure” Patients: A Descriptive Analysis

References

• Demirer, T., Bensinger, W. I. and Buckner, C. D. (1999). Peripheral blood stem cell mobilization for high-dose chemotherapy, J Hematother, 8(2), 103–113.
   PubMedGoogle Scholar
• Glaspy, J. A. (1999). Economic considerations in the use of peripheral blood progenitor cells to support high dose chemotherapy, Bone Marrow Transplant, 23 (Suppl 2): 521–527.
   Google Scholar
• Stiff, P. J. (1999). Management strategies for the hard-to-mobilize patient, Bone Marrow Transplant, 23 (Suppl 2): 529–533.
   PubMedGoogle Scholar
• Dreger, P., Kloss, M. and Petersen, B., et al. (1995). Autologous progenitor cell transplantation: Prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts, Blood, 86, 3970–3978.
   PubMed Web of Science ®Google Scholar
• Pecora, A. L. (1999). Impact of stem cell dose on hematopoietic recovery in autologous blood stem cell recipients, Bone Marrow Transplant, 23(Suppl 2): 57–112.
   Web of Science ®Google Scholar
• Shpall, E. J., Champlin, R. and Glaspy, J. A. (1998). Effect of CD34 + peripheral blood progenitor cell dose on hematopoietic recovery, Biol Blood Marrow Transplant, 4(2), 84–92.
   PubMedGoogle Scholar
• Perez-Simon, J. A., Caballero, M. D. and Corral, M., et al. (1998). Minimal number of circulating CD34 + cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation, Transfusion, 38(4), 385–391.
   PubMed Web of Science ®Google Scholar
• Watts, M. J., Sullivan, A. M. and Leverett, D., et al. (1998). Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization, J Clin Oncol, 16(4), 1554–1560.
   PubMed Web of Science ®Google Scholar
• Weaver, C. H., Tauer, K. and Zhen, B., et al. (1998). Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34 + cell yields, J Hemaiother, 7(3), 241–249.
   PubMedGoogle Scholar
• Gazitt, V., Freytes, C. O. and Callander, N., et al. (1999). Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization, J Hematother, 8, 173–183.
   PubMedGoogle Scholar
• Shpall, E. J. (1999). The utilization of cytokines in stem cell mobilization strategies, Bone Marrow Transplant, 23 (suppl 2): S13–19.
   PubMed Web of Science ®Google Scholar
• Damiani, D., Fanin, R. and Silvestri, F., et al. (1997). Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients, Blood, 90(1), 36–42.
   PubMed Web of Science ®Google Scholar
• Damiani, D., Grimaz, S., Infanti, L., Speretto, A., Silvestri, F., Geromin, A., Cerno, M., Savigano, C., Michieli, M., Skert, C., Fanin, R. and Baccarani, M. (1999). Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients: effect of a brief course of G-CSF on harvest and recovery, Bone Marrow Transplant, 24, 757–761.
   PubMed Web of Science ®Google Scholar
• Visani, G., Lemoli, R. M. and Tosi, P., et al. (1999). Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients, Br J Haematol, 105(3), 775–779.
   PubMed Web of Science ®Google Scholar
• Krieger, M. S., Schiller, G. and Berenson, J. R., et al. (1999). Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34 + cells, Bone Marrow Transplant, 24(1), 25–28.
   PubMed Web of Science ®Google Scholar
• Humpe, A., Riggert, J. and Munzel, U., et al. (1999). A prospective, randomized, sequential, crossover trial of large-volume versus normal-volume leukapheresis procedures: effect on progenitor cells and engraftment, Transfusion, 39(10), 1120–1127.
   PubMed Web of Science ®Google Scholar
• Phillips, G. L., Davey, D. D. and Hale, G. A., et al. (1999). The use of granulocyte-colony stimulating factor (G-CSF)-primed, delayed marrow harvests as a source of hematopoietic stem and progenitor cells for allogeneic transplantation, Leuk Lymph, 35(3–4), 303–309.
   PubMed Web of Science ®Google Scholar
• Dicke, K. A., Hood, D. L. and Ameson, M., et al. (1997). Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting, Exp Hematol, 25(1), 34–38.
   PubMed Web of Science ®Google Scholar
• Drake, M., Ranaghan, L. and Morris, T. C., et al. (1997). Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system, Br J Haematol, 98(3), 745–749.
   PubMed Web of Science ®Google Scholar
• Leonard, B. M., Hetu, F. and Busque, L., et al. (1998). Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources, Blood, 91(1), 331–339.
   PubMed Web of Science ®Google Scholar
• Meisenberg, B., Brehm, T., Schmeckel, A., Miller, W. and McMillan, R. (1998). A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte-colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells, Transfusion, 38(2), 209–215.
   PubMed Web of Science ®Google Scholar
• Armitage, S., Hargreaves, R. and Samson, D., et al. (1997). CD34 counts to predict the adequate collection of peripheral blood progenitor cells, Bone Marrow Transplant, 20(7), 587–591.
   PubMed Web of Science ®Google Scholar
• Mavroudis, D. A., Read, E. J. and Molldrem, J., et al. (1998). T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34 + cell content but is associated with delayed pancytopenia, Bone Marrow Transplant, 21(5), 431–440.
   PubMed Web of Science ®Google Scholar
• Weaver, C. H., Birch, R. and Greco, F. A., et al. (1998). Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim, Br J Haematol, 100(2), 338–347.
   PubMed Web of Science ®Google Scholar
• Stewart, D. A., Guo, D. and Luider, J., et al. (1999). Factors predicting engraftment of autologous blood stem cells: CD34 + subsets inferior to the total CD34 + cell dose, Bone Marrow Transplant, 23(12), 1237–1243.
   PubMed Web of Science ®Google Scholar
• Fujisaki, T., Berger, M. G., Rose-John, S. and Eaves, C. J. (1999). Rapid differentiation of a rare subset of adult human lin(-)CD34+CD38 (-) cells stimulated by multiple growth factors in vitro, Blood, 94(6), 1926–1932.
   PubMed Web of Science ®Google Scholar
• Steen, R., Tjonnfjord, G. E., Gunnes Groseth, L. A., Heldal, D. and Egeland, T. (1997). Efflux of CD34 + cells from bone marrow to peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration, J Hematother, 6(6), 563–573.
   PubMedGoogle Scholar